CEO Maravai LifeSciences CEO Continues Heavy Insider Selling Despite Bull Market – Investors Eye Confidence Signals
Maravai CEO’s latest insider sale shows a “portfolio‑manager” pattern—selling $5.70 avg while still holding 25% stake, hinting at confidence despite market dips.
3 minutes to read